GE HealthCare
(Nasdaq: GEHC)
announced today that it agreed to acquire Intelligent Ultrasound Group’s clinical AI software business.
Intelligent Ultrasound Group offers integrated, AI-driven image analysis tools designed to make ultrasound smarter and more efficient.
The deal includes a total cash consideration of approximately $51 million. GE HealthCare plans to incorporate the newly acquired solutions across its ultrasound portfolio. It aims to strengthen its capabilities through improving workflows and enhancing ease of use for clinicians and patients.
Intelligent Ultrasound Group’s ScanNav Assist AI technology powers its SonoLystlive and SonoLyst X/IR. It offers these solutions on the GE HealthCare Voluson Expert and Voluson Signature ultrasound devices, as well as the Voluson Swift. Acquiring this business brings an AI innovation pipeline to GE HealthCare’s ultrasound efforts, according to a news release.
GE HealthCare said it plans to bring on the team of R&D experts from Intelligent Ultrasound. It expects that group to drive AI-enabled image recognition and innovation for its Women’s Health ultrasound devices and across the broader portfolio. This adds to the company’s 2023 buy of Caption Health, which added capabilities in AI-enabled image guidance.
The company expects the deal to close in the fourth quarter of 2024. It plans to fund the transaction with cash on hand.
“We are pleased to bring innovative technology from Intelligent Ultrasound into GE HealthCare’s Ultrasound portfolio, allowing us to fully integrate these solutions into our systems to help clinicians improve workflow, reduce repetitive tasks, and simplify exams,” said Phil Rackliffe, president and CEO of Ultrasound and Image-Guided Therapies, GE HealthCare. “This technology and the experts who developed it will help enhance our portfolio of AI-enabled devices and accelerate our pace of development of next-generation AI tools.”
